Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
Airgas, Inc. (NYSE: ARG) shares increased 2.77 percent to close at $108.99 a share Tuesday. The stock traded between $107.00 and $109.00 on volume of 600,615 shares traded. Analysts at Global Hunter Securities have recently upgraded the company’s rating to "buy" from "neutral". Shares of Airgas have gained approximately 19.0 percent year-to-date.
Find out more about Airgas including full access to the free equity report at:
Cepheid (NASDAQ: CPHD) shares declined 0.51 percent to close at $38.84 a share Tuesday. The stock traded between $37.77 and $38.94 on volume of 570,046 shares traded. Analysts at Bank of America Merrill Lynch have recently downgraded the company’s rating to "neutral" from "buy". Shares of Cepheid have gained approximately 15.0 percent year-to-date.
Find out more about Cepheid including full access to the free equity report at:
Charles River Laboratories (NYSE: CRL) shares increased 0.78 percent to close at $46.62 a share Tuesday. The stock traded between $46.19 and $47.06 on volume of 523,809 shares traded. Analysts at Cantor have recently initiated coverage on the company with a "buy" rating and a price target of $53.00. Shares of Charles River Laboratories have gained approximately24.0 percent year-to-date.
Find out more about Charles River Laboratories including full access to the free equity report at:
Universal Display Corporation (NASDAQ: OLED) shares declined 3.65 percent to close at $30.86 a share Tuesday. The stock traded between $28.72 and $30.97 on volume of 2.11 million shares traded. Analysts at Canaccord have recently downgraded the company’s rating to "sell" from 'hold". Shares of Universal Display have gained approximately 20.0 percent year-to-date.
Find out more about Universal Display including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Leave a comment...